1st French pharmaceutical company joined IPSeeds Blockchain Platform

DTCO
IPSeeds
Published in
1 min readMar 9, 2017

We hereby announce that Servier officially becomes BioIPSeeds industry member earlier this week. This move will encourage Taiwan academia to release more IP & research project on IPSeeds and accelerate the open innovation process the Pharma Industry needs.

Servier, founded in 1954, is the first independent pharmaceutical group. Servier present in 140 countries, with more than 21,200 employees, including close to 3,000 in R&D. A turnover of 3.9 billion euros in 2015. Servier professionals now have access to IP Projects on the BioIPseeds to fully utilized Taiwan & Global Research Capacity.

IPSeeds is a blockchain platform which allow research inventions to be post securely. The earlier the cross industry collaboration started the better chance companies can successfully develop a solution to address dire medical need. Our IPSeeds team are so excited the change we can make in enabling open innovation in Pharma Industry. As Academia more professionals come to IPSeeds to put their IP to work. BioIPSeeds expects Servier and other member can benefits from the blockchain platform and further increases the success rate of research collaborations.

https://www.ipseeds.net/

--

--